Filing Details

Accession Number:
0001140361-11-040682
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-08-09 16:56:14
Reporting Period:
2011-08-05
Filing Date:
2011-08-09
Accepted Time:
2011-08-09 16:56:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1107421 Ziopharm Oncology Inc ZIOP Services-Specialty Outpatient Facilities, Nec (8093) 841475642
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1091823 J Randal Kirk C/O Legal Department
1881 Grove Avenue
Radford VA 24141
Yes No Yes No
1356090 Intrexon Corp C/O Legal Department
20358 Seneca Meadows Parkway
Germantown MD 20876
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-08-05 116,112 $4.65 116,112 No 4 P Indirect By Kapital Joe, LLC
Common Stock Acquisiton 2011-08-08 444,892 $4.58 561,004 No 4 P Indirect By Kapital Joe, LLC
Common Stock Acquisiton 2011-08-09 285,518 $5.13 846,522 No 4 P Indirect By Kapital Joe, LLC
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Kapital Joe, LLC
No 4 P Indirect By Kapital Joe, LLC
No 4 P Indirect By Kapital Joe, LLC
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 7,973,161 Indirect By Intrexon Corporation
Common Stock 25,000 Direct
Footnotes
  1. Randal J. Kirk controls Kapital Joe, LLC ("Kapital Joe"). Shares held by Kapital Joe may be deemed to be indirectly beneficially owned (as defined under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended) by Mr. Kirk.
  2. Randal J. Kirk, directly and through certain affiliates, has voting and dispositive power over a majority of the outstanding capital stock of Intrexon Corporation. Mr. Kirk may therefore be deemed to have voting and dispositive power over the shares of the issuer owned by Intrexon Corporation. Mr. Kirk disclaims beneficial ownership of such shares, except to the extent of any pecuniary interest therein.